Certara, Inc. · NASDAQ:CERT

Certara — Technical Presentation (August 2014)

16 slides from Certara's technical presentation, Aug 7, 2014

  1. Slide 1: A student's perspective on using Phoenix NLME for popPK analysis of an intranasal combination drug

    A student’s perspective on using Phoenix NLME for popPK analysis of an intranasal combination drug Tim Cacek, PharmD, MS Senior Clinical Pharmacist, Boone Hospital Center Thursday, 7 August 2014 We will begin at 11AM EDT – New York (8AM San Francisco, 4PM London, 5PM Paris) Event Number 921 023 188

  2. Slide 2: Today's Presenter

    Today’s Presenter Dr. Tim Cacek • Senior Clinical Pharmacist at Boone Hospital Center in Columbia, MO • Studied PK alterations in cancer patients with serum protein abnormalities at the MD Anderson Cancer Center • Received a BS in Pharmacy from South Dakota State University and PharmD from the Medic

  3. Slide 3: As a Student

    As a Student • Stay organized within Phoenix • Model setup • Familiarize yourself with tab and graph outputs • Technical and theoretical considerations • Use reasonable PK parameters and associations • Follow popPK and NCA example • Be patient (“Not responding”, locked) © Copyright 2013 Certara, L.P

  4. Slide 4: Steps involved in popPK analysis

    Steps involved in popPK analysis Data Preparation Data Exploration - Graphical Noncompartmental Analysis Model Development Structural Model Covariate Analysis Random Effects Model Validation Internal External Simulation © Copyright 2013 Certara, L.P. All rights reserved.

  5. Slide 5: Kovacaine - The client: St. Renatus

    The client: St. Renatus Kovacaine © Copyright 2013 Certara, L.P. All rights reserved.

  6. Slide 6: Protocols and Covariates

    Protocols 202 206 207 15 Volunteers 24 Volunteers Pediatrics 18 Volunteers 0.1/6 mg Q 4 min X 3 10 kg to <20 kg: 0.1/6 mg Q 4 min X 3 3/0.05mg 0.2/12 mg Q 4 min X 6 20 kg to <40 kg: 6/0.1mg 40 kg or more: 12/0.2 mg 2 hour rich sampling 24 hour rich sampling 24hr sampling 0, 5, 10, 15, 20, 25, 30, 40

  7. Slide 7: A pharma/academia collaboration

    A pharma/academia collaboration Business - Product Development - Regulatory Requirements - Time Lines – Target Dates Academics Time is of the essence - Special Project - Population Modeling © Copyright 2013 Certara, L.P. All rights reserved.

  8. Slide 8: © Copyright 2013 Certara, L.P. All rights reserved.

    © Copyright 2013 Certara, L.P. All rights reserved.

  9. Slide 9: Phoenix NLME has an intuitive GUI.

    Phoenix NLME has an intuitive GUI. © Copyright 2013 Certara, L.P. All rights reserved.

  10. Slide 10: © Copyright 2013 Certara, L.P. All rights reserved.

    © Copyright 2013 Certara, L.P. All rights reserved.

  11. Slide 11: Plots of Interest

    Plots of Interest • Covariate Plots (Box and XY) • DV vs IPRED • DV vs PRED • CWRES vs Pred (TAD) • DV, PRED, IPRED vs TAD Lattice • Convergence © Copyright 2013 Certara, L.P. All rights reserved.

  12. Slide 12: Result Tabs of Interest

    Result Tabs of Interest • Overall • Theta – Parameter estimates, precision, CIs • Omega – Between subject variability - √omega • Omega Stderr – Precision of BSV • StrCovariate (categorical and continuous) • Boot Tables (Theta, Omega) • Residuals – Use for graph generation © Copyright 2013 Certara, L

  13. Slide 13: Option to Export Data and Results

    Option to Export Data and Results © Copyright 2013 Certara, L.P. All rights reserved.

  14. Slide 14: Increase Speed/Save Space

    Increase Speed/Save Space • Minimize graphics • Be selective in NCA parameters • Multiple project files (validation) • Multiple Data Wizards • Replicate count • Be Patient ------------------- © Copyright 2013 Certara, L.P. All rights reserved.

  15. Slide 15: Kovacaine Today?

    Kovacaine Today? • First population and detailed PK profile • Questions answered • Initial popPK result statements included in FDA required documents • Manuscript in preparation • Pharmacodynamic modeling is anticipated © Copyright 2013 Certara, L.P. All rights reserved.

  16. Slide 16: Contacts & Follow-Up: Thank you!

    Contacts & Follow-Up: Thank you! Americas Telephone (US): 888-708-7444 Telephone (Intl): +1-919-852-4636 Email: sales@certara.com Europe Telephone: +44 203 287 0010 Email: sales@certara.com India Telephone: +91 984 500 6625 Email: sales@certara.com Japan Telephone: +81 (0)50-3786-9898 Email: sales@c

Certara — Technical Presentation (August 2014) on 6ix